GGHC
KLRS

Gilder Gagnon Howe & Co’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-575
Closed -$509K – 412
2020
Q4 		$509K Sell
575
-26
-4% -$23K ﹤0.01% 285
2020
Q3 		$380K Buy
+601
New +$380K ﹤0.01% 286